Abstract
The study aimed to determine the specific relative biological effectiveness (RBE) of various cells in the hippocampus following proton irradiation. Sixty Sprague–Dawley rats were randomly allocated to 5 groups receiving 20 or 30 Gy of proton or photon irradiation. Pathomorphological neuronal damage in the hippocampus was assessed using Hematoxylin–eosin (HE) staining. The expression level of NeuN, Nestin, Caspase-3, Olig2, CD68 and CD45 were determined by immunohistochemistry (IHC). The RBE range established by comparing the effects of proton and photon irradiation at equivalent biological outcomes. Proton20Gy induced more severe damage to neurons than photon20Gy, but showed no difference compared to photon30Gy. The RBE of neuron was determined to be 1.65. Similarly, both proton20Gy and proton30Gy resulted in more inhibition of oligodendrocytes and activation of microglia in the hippocampal regions than photon20Gy and photon30Gy. However, the expression of Olig2 was higher and CD68 was lower in the proton20Gy group than in the photon30Gy group. The RBE of oligodendrocyte and microglia was estimated to be between 1.1 to 1.65. For neural stem cells (NSCs) and immune cells, there were no significant difference in the expression of Nestin and CD45 between proton and photon irradiation (both 20 and 30 Gy). Therefore, the RBE for NSCs and immune cell was determined to be 1.1. These findings highlight the varying RBE values of different cells in the hippocampus in vivo. Moreover, the actual RBE of the hippocampus may be higher than 1.1, suggesting that using as RBE value of 1.1 in clinical practice may underestimate the toxicities induced by proton radiation.
Similar content being viewed by others
Introduction
Malignant brain tumors mainly include primary and secondary types, both of which pose a significant threat to patient lives and have poor prognoses. Radiotherapy (RT) has been shown to be effective in improving the overall survival (OS) and local control rate (LCR) of patients with cerebral malignancies1,2. Proton beam therapy (PBT) is one of the most advanced RT modalities available globally, leveraging a unique physics advantage known as the Bragg peak. This feature is considered to offer a more precise tumor control dose and lower treatment-related toxicity than photon therapy3,4,5. Currently, the prescribed dose of protons used in clinical applications is typically determined by a constant relative biological effectiveness (RBE) of 1:16,7. RBE is defined as the ratio of photon versus proton dose when producing the same biological effect8. However, the RBE of proton (1.1) was derived from cell proliferation experiments conducted by previous researchers, and further in vivo experiments are needed to validate these findings.
At present, a growing number of studies have found that proton RBE is variable. Solely relying on a fixed value of 1.1 may lead to seriously underestimation of the effect of protons on normal tissue damage, potentially resulting in a higher incidence and severity of radiotoxicity, particularly in organs such as heart and lungs9,10. Similarly, radiation-induced brain injury (RIBI) has also been observed clinically after proton therapy11,12. RIBI includes not only acute adverse effects such as headache, dizziness, nausea and drowsiness13, but also delayed brain injury, characterized by hippocampal-related learning and cognitive impairment and brain necrosis which even can eventually lead to uncontrolled brain herniation and death14. Prezado et al. found that radio-necrosis of brain tissue could be induced when rats were irradiated with protons (25 Gy or more)15. Williams et al. found that rats exposed to 14 and 17 Gy proton irradiation were defective in the Morris water maze task test, which reflected hippocampal learning and memory function16. Lawrence et al. concluded that the five-year risk of RIBI with normally fractionated RT at total doses of 72 Gy was ~ 5%17. The hippocampus is highly sensitive to radiation and is one of the most important organs at risk (OAR) in cranial RT18. It had been demonstrated that that exposure to high linear energy transfer (LET) irradiation caused short- and long-term flaws in hippocampus-dependent cognition and learning19,and could also lead to severe dysfunction of the central nervous system (CNS)20. Therefore, it is very crucial to protect brain tissues, especially the hippocampal region, during RT.
Various factors can influence the variation of proton RBE, such as the radiation dose/fraction, α/β, LET, and biological end points6. The dependence of RBE on tissue-specific α/β ratio is well-established21. Previous studies have indicated that the neurological tissues typically have a lower α/β ratio22, and tissues with low α/β values show higher RBE values than those with high α/β values23. Due to the heterogeneity of the brain, irradiation may have different biological effects in different brain areas. Despite great efforts have been taken to estimate clinical RBE using mathematical models7, the true RBE of normal brain tissues remains unknown. Additionally, as protons decelerate, LET increases with depth, potentially leading to higher RBE in normal tissue below the target area24. Given the anatomical location of the hippocampus beneath tumor targets and its composition of neurons, oligodendrocytes, microglia and neural stem cells (NSCs) in the subgranular zone (SGZ) of dentate gyrus (DG), it is speculated that the RBE of the hippocampus may be higher than 1.125. In vitro experiments confirmed the RBE of ~ 1.35 for glioma U87 when LET = 2.626. Clonogenic assay showed that the RBE of skin fibroblasts between 1.4 and 2.2 when LET of 2 to 2.626,27. To date, there have been no relevant studies have explored the actual RBE of the hippocampus by comparing the damage differences in different cells caused by proton versus photon irradiation.
Therefore, this study aims to investigate the difference of biological effects of different cells in hippocampus after proton and photon irradiation by using a rat model of RIBI, and subsequently calculate the RBE for different cells. This will be crucial for accurately determining the RBE values of brain tissue, thereby significantly advancing the clinical application of PBT in malignant brain tumors and promoting the dawn of an era of precise proton therapy for malignant brain tumors.
Materials and methods
Rats and irradiation procedures
Sixty healthy male rats (6-week-old, Sprague–Dawley (SD), 200–220 g, from Jinan Pengyue Laboratory Animal Breeding Co. Ltd.) were housed in a sterile animal house under a 12:12-h light–dark cycle, with free access to water and food. Ethics statement: All animal experiments were conducted in accordance with the animal welfare and ethical guidelines and approval was granted by the Ethics Committee of Shandong Cancer Hospital (ID: 201911022). And the study was carried out in accordance with ARRIVE guidelines.
A rat model of acute RIBI needed to be established in this study, therefore, two doses of 20 Gy and 30 Gy were selected for whole brain radiation in rats (proton dose was converted to photon dose according to 1:1.1). Rats were randomly grouped as follows (n = 12): proton20 (20 Gy, RBE), proton30 (30 Gy, RBE), photon20 (20 Gy), photon30 (30 Gy) and control.
Proton irradiation was performed using a proton radiation accelerator (PROTEUS235 proton therapy system from IBA, Belgium). The anesthetized rats were fixed on the radiation table and exposed to the radiation area, using the intersection of the median line of the parietal bone of the skull and the posterior line of the two ears of the rats as the irradiation localization center, the axial distance of the source was adjusted to be 230 cm, and the proton beams had an energy of 230 MeV and a dose rate of 2 Gy/min, the depth and width of the SOBP were measured by the water tank before exposure, and 3 cm of SOBP was obtained by the range modulator to ensure the uniformity of the radiation dose to the whole brain of the rats. Detailed irradiation parameters can be found as Supplementary Table S1 online.
Photon irradiation was performed by using a photon linear accelerator (Valerian VitalBeam, USA) with a dose rate of 1400 MU/min and an energy of 6 MV, adjusting the source skin distance to 100 cm and covering the head with a 1-cm tissue-equivalent membrane. All rats were anesthetized with isoflurane (2.5% in air) before irradiation.
Follow-up processing
The rats were anesthetized and euthanized by intraperitoneal injection of 50 mg/kg pentobarbital sodium. Half of all groups’ rats were sacrificed at 24 h and the other half rats were sacrificed at 7 days post-irradiation. Brain fixation was performed by trans-cardiac perfusion with heparin-containing 0.9% saline followed by a rapid drip of 4% paraformaldehyde. Then the brains were removed, and the 3-mm-thick blocks of tissue in coronal section from the hippocampal region were immersed in 10% formalin for 24 h. The pathological tissue wax blocks were prepared by paraffin embedding, and the consecutive coronal sections were made with a thickness of 3 um. Hematoxylin–eosin staining (HE staining) was performed, scanned using Zeiss digital slice scanner and observed by ZEN (BLUE) 2012 software, and two pathologists were asked to (double-blind) analyze and count the damaged neurons in each subregion of the hippocampus in the same coronal plane of pathology sections, with four random fields of view selected for each subregion, then the ratio of damaged neurons to all the neurons under the field of view was calculated. Damaged neurons included dark neurons, necrotic neurons and apoptotic neurons, which were cytomorphologically defined as eosinostaining enhanced, cytoplasmic looseness, nucleolar segregation, shrunken and deformed cytoplasm, hyperchromatic nucleus, karyopyknosis and karyolysis. Immunohistochemistry (IHC) analysis was performed to assess the expression of NeuN (Abcam, dilution: 1:200), Nestin (ABclonal, dilution: 1:100), Caspase-3 (Proteintech, dilution: 1:300), Olig2 (Venus gene, dilution: 1:200), CD68 (Venus gene, dilution: 1:100) and CD45 (Venus gene, dilution: 1:500) in the brain. Average optical density (AOD) was performed using ImageJ software version 1.54 (NIH, Bethesda, MD) to assess the density of positive cells.
RBE was defined as the ratio of the photon and proton dose when these two irradiation types produce equivalent biology output. Consider that different cells in the hippocampus have different effects after irradiation, we determined different biological output of them. The specific algorithm of the RBE range in different types of cells were showed in Table 1.
Statistics
After normality testing (Shapiro–Wilk test), the differences between the three groups were analyzed using one-way Analysis of Variance (ANOVA) followed by Fisher’s least significant difference (LSD) post-hoc test. Two-sided unpaired Student’s t-test or Mann–Whitney U test was used for comparison of two groups. Results were considered statistically significant when p < 0.05. Data are presented as mean ± the standard error of the mean (SEM). All statistical analyses were performed using SPSS v26.0 (IBM, Chicago, Illinois, USA) or GraphPad Prism Software v9.5 (GraphPad, San Diego, California, USA).
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. And the study is reported in accordance with ARRIVE guidelines. Approval was granted by the Ethics Committee of Shandong Cancer Hospital (No: 201911022).
Results
Differences in damage of neurons caused by proton versus photon irradiation
In the early phase of acute injury (24 h after irradiation), irregular arrangement of hippocampal neurons, loose cytoplasm, shrunken and deformed cytoplasm, hyperchromatic nucleus, karyopyknosis, karyorrhexis and karyolysis could be observed in the HE-stained sections of both the proton and photon groups compared with the control group (Fig. 1a). The degree of injury was found to be dose-dependent (Fig. 1d).
Protons caused more severe neuronal damage than photons at 24 h post-irradiation, no matter the dose was 20 or 30 Gy. HE staining results showed that the overall neuronal damage rate was approximately 10% higher in the proton group than in the photon group (20 Gy: p < 0.001, 30 Gy: p = 0.047). Subsequently, neuronal damage was assessed in each hippocampal subregion (Supplementary Fig. S1 online). The results showed that a significantly higher rate of neuronal damage in the proton group compared to the photon group across CA1, CA2, CA3, and CA4 regions (Table 2). While there was a difference in neuronal damage in the DG region, it did not reach statistical significance (Table 2). Similarly, IHC analysis using NeuN and Caspase-3 markers further supported that both the degree of neuronal damage and the level of apoptosis were more severe in the proton group than that in the photon group (NeuN: p = 0.027, p = 0.049, Fig. 1b,g, Tables 2; Caspase-3: p = 0.048, p = 0.162, Fig. 1c,h, Tables 2). The expression extent of neurons and the level of apoptosis demonstrated by IHC after irradiation also show a dose-dependent relationship (Fig. 1e,f).
At the late phase of acute injury (7 days after irradiation), HE staining revealed no significant differences in the rate of neuronal damage between proton group and the photon group in each subregion (Table 2). Similarly, there was no significant difference in the expression of NeuN between the two groups (20 Gy: p = 0.069, 30 Gy: p = 0.602, Fig. 1g). While there was no significant difference between the groups after 20 Gy irradiation (p = 0.194, Fig. 1h), the expression of Caspase-3 was lower in the proton group compared to the photon group after 30 Gy irradiation (p = 0.016, Fig. 1h).
Differences in the effects of proton versus photon irradiation on NSCs
IHC analysis was utilized to detect Nestin-positive cells and evaluate the effects of proton versus photon irradiation on hippocampal NSCs (Fig. 2a). The results indicated that irradiation could up-regulate the expression levels of Nestin, with significant differences observed between the proton or photon groups and the control group (all p < 0.001). After 24 h post-irradiation, the expression of Nestin in the proton group was slightly higher than that in photon group, although this difference was not statistically significant (20 Gy: 0.174 ± 0.004 vs. 0.166 ± 0.002, p = 0.081, Fig. 2b; 30 Gy: 0.184 ± 0.009 vs. 0.173 ± 0.004, p = 0.637, Fig. 2c). This suggests that proton-induced activation of hippocampal NSCs occurs more rapidly in the initial phase of injury than that induced by photons. After 7 days, the Nestin immunoreactivity in the proton group became slightly weaker than in the photon group (20 Gy: 0.148 ± 0.003 vs. 0.151 ± 0.002, p = 0.370, Fig. 2d; 30 Gy: 0.140 ± 0.003 vs. 0.149 ± 0.004, p = 0.075, Fig. 2e).
Differences in the effects of proton versus photon irradiation on glial cells
Protons significantly reduced the number of oligodendrocytes in the hippocampus compared to photons (Fig. 3a). IHC analysis showed that the AOD of Olig2 in the proton group was significantly lower than in the photon group (20 Gy: 0.455 ± 0.007 vs. 0.485 ± 0.010, p = 0.044, Fig. 3b; 30 Gy: 0.418 ± 0.003 vs. 0.435 ± 0.005, p = 0.045, Fig. 3c), and this differences still observable even at 7 days post-irradiation (20 Gy: 0.430 ± 0.012 vs. 0.478 ± 0.006, p = 0.022; Fig. 3d; 30 Gy: 0.420 ± 0.003 vs. 0.458 ± 0.009, p = 0.001, Fig. 3e).
However, the changes in microglia after irradiation were opposite to those of oligodendrocytes. Proton irradiation significantly increased the number of activated microglia compared to photon irradiation (Fig. 4a). Whether at 24 h or 7 days after irradiation, the expression of CD68 in hippocampus was higher in the proton-treated group than in the photon-treated group (24 h: 20 Gy: 0.360 ± 0.001 vs. 0.343 ± 0.002, p < 0.001, Fig. 4b; 30 Gy: 0.388 ± 0.003 vs. 0.371 ± 0.004, p = 0.022, Fig. 4c; 7d: 20 Gy: 0.370 ± 0.006 vs. 0.345 ± 0.008, p = 0.022, Fig. 4d; 30 Gy: 0.386 ± 0.010 vs. 0.355 ± 0.008, p = 0.014; Fig. 4e). In summary, proton therapy appears to induce a greater activation of microglia compared to photon therapy.
Differences between photon and photon irradiation in influencing immune cell aggregation
The results of IHC analysis revealed that both proton and photon radiation exhibited similar levels of CD45 expression in 24 h after exposure, regardless of whether in the 20 Gy or the 30 Gy group (20 Gy: 0.367 ± 0.008 vs. 0.350 ± 0.004, p = 0.098, Fig. 5a; 30 Gy: 0.385 ± 0.011 vs. 0.379 ± 0.005, p = 0.607, Fig. 5b). One week after irradiation, CD45 expression in both groups remained consistent on the 7th day (20 Gy: 0.372 ± 0.003 vs. 0.364 ± 0.007, p = 0.381, Fig. 5c; 30 Gy: 0.399 ± 0.008 vs. 0.388 ± 0.010, p = 0.371, Fig. 5d). In conclusion, regardless of dosage or timing, the results demonstrate no significant differences in the impacts of proton and photon radiation on immune cells.
Real RBE values of different cells in the hippocampus after proton irradiation
Over time, multiple confounders such as immune cells and inflammatory factors have been involved in the effects of brain tissue damage. It is now recognized that calculating RBE solely based on a single biological endpoint is no longer feasible. Therefore, the RBE values was calculated in various cell types during the early stage of acute injury (24 h post-irradiation, Table 3). The results showed that proton-induced neuronal damage was more severe compared to photon-induced damage when assessing biological equivalent doses (proton20 vs. photon20: p < 0.001, proton30 vs. photon30: p = 0.047). However, there was no significant difference between the proton20 group and the photon30 group (proton20 vs. photon30: p = 0.550), reaching an equivalent biological end point. Consequently, the actual RBE of neuron cells was calculated to be 1.65 according 30 Gy/ (20/1.1) Gy. Applying the same method, it was observed that protons had a greater impact on oligodendrocytes and microglia compared to photons under equivalent biological dose irradiation (oligodendrocyte: p = 0.044 and p = 0.045; microglia: p < 0.001 and p = 0.022). Nonetheless, when comparing the proton20 with photon30 group, the biological effect of the photon30 group was still higher and did not reach the equivalent biological endpoint (oligodendrocyte: p = 0.040; microglia: p = 0.048). Therefore, the actual RBEs of both oligodendrocytes and microglia were estimated to be between 1.1 and 1.65. In contrast, for NSCs and immune cells, both proton and photon irradiation groups reached effective biological endpoints at equivalent biological doses. Thus, the actual RBEs of NSCs and immune cells were suggested to be around 1.1.
Discussion
Our results showed that 24 h post-irradiation, neuronal damage was more severe in terms of pathological morphology in the proton group compared to the photon group (20 Gy: p < 0.001, 30 Gy: p = 0.047). Protons exhibited stronger abilities to inhibit neurons and promote cell apoptosis than photons (20 Gy: p = 0.027 and p = 0.048), with a RBE 1.65 for neuronal cells. These results indicate that protons cause more severe damage to neurons than photons at equivalent biological doses of radiation. At present, most of related studies focus on the differences in tumor tissues and cells following proton and photon irradiation, limited studies have focused on the impact on normal tissues after irradiation. For instance, Choi et al. observed that irradiation of normal intestinal tissues in mice with 6-MV photons or 230-MeV protons resulted in higher apoptotic cell death in the jejunum with proton irradiation (p < 0.001), indicating increased gastrointestinal toxicity28. Furthermore, studies specifically addressing the hippocampus are scarce. Parihar et al. found that exposure to proton irradiation led to more pronounced disruptions in dendritic morphology compared to photon irradiation29. Howe and Kiffer et al. demonstrated that radiation significantly reduced mushroom spine density in the hippocampal CA1, CA3 and DG regions, suggesting detrimental effects on mature neurons associated with learning and memory in the hippocampus30. These findings are in agreement with ours. From the molecular mechanism perspective, the difference in cell killing between protons and photons may be more intricate7. The amount of activated γ-H2AX can be used to assess the amount of DNA damage31. Studies have shown contrasting results, with Gerelchuluun et al. demonstrating a significantly increase in γ-H2AX levels in human tumor cell lines ONS76 and MOLT4, 30 min after 2 Gy irradiation with 200 MeV of proton compared with 10 MV of X-ray irradiation (ONS76: p = 0.006; MOLT4: p = 0.025)32. Conversely, Dokic et al. found that the number of γ-H2AX positive nuclei in the brains of healthy C57BL/6 mice was significantly reduced at 7 days compared with 1 h after proton irradiation, indicating DNA damage repair33. Lohberger et al. also suggested that proton irradiation activated DNA repair mechanisms more effective than photon did34. In this study, no significant difference in pathomorphology of neurons and the expression of NeuN in IHC at 7 days after irradiation between proton and photon groups (p > 0.05), which indicates that the mechanism of DNA damage repair after proton irradiation is not the same as that of photon, resulting in different rates of DNA repair. Besides, ionizing radiation also leads to the production of reactive oxygen species (ROS) that can damage DNA indirectly by reacting with molecular oxygen to form stable DNA peroxides31. Giedzinksi et al. observed that elevated ROS levels in rat hippocampal neural precursor cells after exposure to protons near the Bragg peak at 250 MeV compared to X-rays (p < 0.05)35. In summary, we propose that the RBE of neurons is likely higher than 1.1. Therefore, in PBT for brain tumors, minimizing radiation exposure to hippocampal neurons while ensuring therapeutic efficacy is crucial.
It should be noted that the effects of proton radiation on NSCs are different from those of neurons. Radiation may stimulate the activation and redifferentiation of NSCs, which mainly located in the subventricular zone (SVZ) and the SGZ in the adult brain. NSCs are highly sensitive to ionizing radiation and have the ability to differentiate into neurons, oligodendrocytes and microglia36. Nestin protein, also known as neuroepithelial stem cell protein, is an embryonic intermediate filament protein abundantly presented in the proliferative zone of the CNS37. While Nestin is minimally expressed in mature neurons and glial cells, its levels increase in damaged neural tissue38,39. IHC analysis revealed that proton radiation led to a higher expression of Nestin compared to photon radiation 24 h post-irradiation, although the difference was not statistically significant (p > 0.05). Therefore, the RBE for NSCs is 1.1. The elevated expression of Nestin reflects the activated state of NSCs, and its proteins, may protect the nervous system from injury by promoting cell proliferation, differentiation, and neuroglial scar formation, as well as promoting the formation of new synapses in neurons, represents neurogenesis or neuroremodeling40. This suggests that proton may be more effective than photon in promoting NSCs differentiation at early phase after irradiation. It is plausible that this mechanism contributes to the diminishing disparity in neuronal damage between protons and photons beyond 7 days post-irradiation.
The biological effects of proton and photon irradiation are also different for other types of cells in brain tissue. Olig2, a key factor in oligodendrocyte transcription41, is specifically expressed in normal brain oligodendrocytes. Our study observed a significant decrease in Olig2 expression in brain tissue following proton irradiation compared to photon irradiation (20 Gy: p = 0.044; 30 Gy: p = 0.045). As a result, the RBE of oligodendrocytes ranged from 1.1 to 1.65, indicating a stronger inhibitory effect of protons on oligodendrocytes compared to photons. The reduction of oligodendrocyte, which is required for myelination, eventually leads to demyelination of brain neurons and necrosis of the white matter42. Therefore, a reduction in oligodendrocyte leads to further neuronal damage and a decrease in the overall number of neurons.
Previous studies have shown that the increase in inflammation-associated cytokines (such as IL-6, IL-1β, TNF-α and so on) after RT is mainly related to the activation of microglia43, over-activated microglia induce neuronal death and inhibit neuronal regeneration, leading to cognitive impairment in patients43,44,45. CD68 is a marker for activated microglia46. Dokic et al. found that CD68 signal in mouse brain increased 1.75-fold at 7 days after proton irradiation compared with the control samples (p < 0.05)33. The data of this study showed that the positive expression rate of CD68 in proton group was significantly higher than that in photon group, both at 20 Gy and 30 Gy (20 Gy: p < 0.001; 30 Gy: p = 0.022), suggesting that protons are more effective than photons in stimulating the activation and proliferation of microglia in the brain. As a result, the RBE of microglia was falls within the range of 1.1–1.65.
Radiation can also cause infiltration of large numbers of immune cells in brain tissue, which participate in the neuroinflammatory response in the brain. Long-term exposure leads to RIBI, which in turn causes hippocampal dysfunction47. CD45, a receptor-linked protein tyrosine phosphatase expressed on all immune cells48, was found to have similar expression levels between proton and photon irradiation (RBE = 1.1), implying that both modes of irradiation may have comparable effects on activating immune cells in the brain. This similarity is attributed to the disruption of the blood–brain barrier, allowing peripheral immune cells into the brain. The interaction of these immune cells is a dynamic and long-term process, necessitating an extended observation period to discern differences in how the two modes of irradiation affect immune cells.
Conclusion
Our data confirm that protons are more powerful than photons in damaging neurons, promoting apoptosis, activating NSCs, inhibiting oligodendrocytes and activating microglia in the hippocampus, eventually leading to increased radiation toxicity. Therefore, the actual RBE of protons in the hippocampus must be higher than 1.1. It is suggested that we should pay more attention to protect hippocampus by control its dose of exposure as much as possible in clinical proton therapy. Further research is necessary to establish the ideal therapeutic dose and irradiation range for PBT in brain malignancies.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Schaff, L. R. & Mellinghoff, I. K. Glioblastoma and other primary brain malignancies in adults. Jama 329, 574. https://doi.org/10.1001/jama.2023.0023 (2023).
Lacas, B. et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 18, 1221–1237. https://doi.org/10.1016/s1470-2045(17)30458-8 (2017).
Lin, S. H. et al. Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J. Clin. Oncol. 38, 1569–1579. https://doi.org/10.1200/jco.19.02503 (2020).
Brown, P. D. et al. A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma. Neuro-Oncology 23, 1337–1347. https://doi.org/10.1093/neuonc/noab040 (2021).
Depauw, N. et al. A novel approach to postmastectomy radiation therapy using scanned proton beams. Int. J. Radiat. Oncol. Biol. Phys. 91, 427–434. https://doi.org/10.1016/j.ijrobp.2014.10.039 (2015).
Paganetti, H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys. Med. Biol. 59, R419-472. https://doi.org/10.1088/0031-9155/59/22/r419 (2014).
Paganetti, H. et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 53, 407–421. https://doi.org/10.1016/s0360-3016(02)02754-2 (2002).
Girdhani, S., Sachs, R. & Hlatky, L. Biological effects of proton radiation: what we know and don’t know. Radiat. Res. 179, 257–272. https://doi.org/10.1667/rr2839.1 (2013).
Chaouni, S. et al. Biological effects of scattered versus scanned proton beams on normal tissues in total body irradiated mice: Survival, genotoxicity, oxidative stress and inflammation. Antioxidants 9, 1170. https://doi.org/10.3390/antiox9121170 (2020).
Underwood, T. S. A. et al. Asymptomatic late-phase radiographic changes among chest-wall patients are associated with a proton RBE exceeding 11. Int. J. Radiat. Oncol. Biol. Phys. 101, 809–819. https://doi.org/10.1016/j.ijrobp.2018.03.037 (2018).
Giantsoudi, D. et al. Incidence of CNS injury for a cohort of 111 patients treated with proton therapy for medulloblastoma: LET and RBE associations for areas of injury. Int. J. Radiat. Oncol. Biol. Phys. 95, 287–296. https://doi.org/10.1016/j.ijrobp.2015.09.015 (2016).
Kralik, S. F. et al. Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy. AJNR Am. J. Neuroradiol. 36, 1572–1578. https://doi.org/10.3174/ajnr.A4333 (2015).
Soussain, C. et al. CNS complications of radiotherapy and chemotherapy. Lancet 374, 1639–1651. https://doi.org/10.1016/S0140-6736(09)61299-X (2009).
Winter, S. F. et al. Treatment-induced brain tissue necrosis: A clinical challenge in neuro-oncology. Neuro Oncol. 21, 1118–1130. https://doi.org/10.1093/neuonc/noz048 (2019).
Prezado, Y. et al. Proton minibeam radiation therapy spares normal rat brain: Long-term clinical, radiological and histopathological analysis. Sci Rep 7, 14403. https://doi.org/10.1038/s41598-017-14786-y (2017).
Williams, M. T. et al. Whole brain proton irradiation in adult Sprague Dawley rats produces dose dependent and non-dependent cognitive, behavioral, and dopaminergic effects. Sci. Rep. 10, 21584. https://doi.org/10.1038/s41598-020-78128-1 (2020).
Lawrence, Y. R. et al. Radiation dose-volume effects in the brain. Int. J. Radiat. Oncol. Biol. Phys. 76, S20-27. https://doi.org/10.1016/j.ijrobp.2009.02.091 (2010).
Raber, J. et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat. Res. 162, 39–47. https://doi.org/10.1667/rr3206 (2004).
Manda, K., Ueno, M. & Anzai, K. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: Ameliorative potential of the melatonin metabolite. AFMK. J. Pineal Res. 45, 430–438. https://doi.org/10.1111/j.1600-079X.2008.00611.x (2008).
Belov, O. V. et al. Exposure to (12)C particles alters the normal dynamics of brain monoamine metabolism and behaviour in rats. Phys. Med. 32, 1088–1094. https://doi.org/10.1016/j.ejmp.2016.08.006 (2016).
McNamara, A. L., Schuemann, J. & Paganetti, H. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data. Phys. Med. Biol. 60, 8399–8416. https://doi.org/10.1088/0031-9155/60/21/8399 (2015).
Underwood, T. S. A. et al. A systematic review of clinical studies on variable proton relative biological effectiveness (RBE). Radiother. Oncol. 175, 79–92. https://doi.org/10.1016/j.radonc.2022.08.014 (2022).
Gerweck, L. E. & Kozin, S. V. Relative biological effectiveness of proton beams in clinical therapy. Radiother. Oncol. 50, 135–142. https://doi.org/10.1016/s0167-8140(98)00092-9 (1999).
Niemierko, A. et al. Brain necrosis in adult patients after proton therapy: Is there evidence for dependency on linear energy transfer?. Int. J. Radiat. Oncol. Biol. Phys. 109, 109–119. https://doi.org/10.1016/j.ijrobp.2020.08.058 (2021).
Paganetti, H. Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy. Int. J. Radiat. Oncol. Biol. Phys. 112, 222–236. https://doi.org/10.1016/j.ijrobp.2021.08.015 (2022).
Chaudhary, P. et al. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: A preclinical assessment. Int. J. Radiat. Oncol. Biol. Phys. 90, 27–35. https://doi.org/10.1016/j.ijrobp.2014.05.010 (2014).
Marshall, T. I. et al. Investigating the implications of a variable RBE on proton dose fractionation across a clinical pencil beam scanned spread-out Bragg peak. Int. J. Radiat. Oncol. Biol. Phys. 95, 70–77. https://doi.org/10.1016/j.ijrobp.2016.02.029 (2016).
Choi, C. et al. Comparison of proton and photon beam irradiation in radiation-induced intestinal injury using a mouse model. Int. J. Mol. Sci. 20, 1894. https://doi.org/10.3390/ijms20081894 (2019).
Parihar, V. K. et al. Persistent changes in neuronal structure and synaptic plasticity caused by proton irradiation. Brain Struct. Funct. 220, 1161–1171. https://doi.org/10.1007/s00429-014-0709-9 (2015).
Howe, A. et al. Long-term changes in cognition and physiology after low-dose (16)O irradiation. Int. J. Mol. Sci. 20, 188. https://doi.org/10.3390/ijms20010188 (2019).
Vanderwaeren, L., Dok, R., Verstrepen, K. & Nuyts, S. Clinical progress in proton radiotherapy: Biological unknowns. Cancers 13, 604. https://doi.org/10.3390/cancers13040604 (2021).
Gerelchuluun, A. et al. Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines. Int. J. Radiat. Biol. 87, 57–70. https://doi.org/10.3109/09553002.2010.518201 (2011).
Dokic, I. et al. Neuroprotective effects of ultra-high dose rate FLASH Bragg peak proton irradiation. Int. J. Radiat. Oncol. Biol. Phys. 113, 614–623. https://doi.org/10.1016/j.ijrobp.2022.02.020 (2022).
Lohberger, B. et al. Activation of efficient DNA repair mechanisms after photon and proton irradiation of human chondrosarcoma cells. Sci. Rep. 11, 24116. https://doi.org/10.1038/s41598-021-03529-9 (2021).
Giedzinski, E., Rola, R., Fike, J. R. & Limoli, C. L. Efficient production of reactive oxygen species in neural precursor cells after exposure to 250 MeV protons. Radiat. Res. 164, 540–544. https://doi.org/10.1667/rr3369.1 (2005).
Gonçalves, J. T., Schafer, S. T. & Gage, F. H. Adult neurogenesis in the hippocampus: From stem cells to behavior. Cell 167, 897–914. https://doi.org/10.1016/j.cell.2016.10.021 (2016).
Bernal, A. & Arranz, L. Nestin-expressing progenitor cells: Function, identity and therapeutic implications. Cell. Mol. Life Sci. 75, 2177–2195. https://doi.org/10.1007/s00018-018-2794-z (2018).
Lendahl, U., Zimmerman, L. B. & McKay, R. D. CNS stem cells express a new class of intermediate filament protein. Cell 60, 585–595. https://doi.org/10.1016/0092-8674(90)90662-x (1990).
Berg, D. A. et al. A common embryonic origin of stem cells drives developmental and adult neurogenesis. Cell 177, 654-668.e615. https://doi.org/10.1016/j.cell.2019.02.010 (2019).
Shi, M., Wei, L. C., Cao, R. & Chen, L. W. Enhancement of nestin protein-immunoreactivity induced by ionizing radiation in the forebrain ependymal regions of rats. Neurosci. Res. 44, 475–481. https://doi.org/10.1016/s0168-0102(02)00175-x (2002).
Lu, Q. R. et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109, 75–86. https://doi.org/10.1016/s0092-8674(02)00678-5 (2002).
Kuhn, S., Gritti, L., Crooks, D. & Dombrowski, Y. Oligodendrocytes in development, myelin generation and beyond. Cells 8, 1424. https://doi.org/10.3390/cells8111424 (2019).
Peng, Y. et al. Blockade of Kv1.3 channels ameliorates radiation-induced brain injury. Neuro Oncol. 16, 528–539. https://doi.org/10.1093/neuonc/not221 (2014).
Son, Y., Yang, M., Wang, H. & Moon, C. Hippocampal dysfunctions caused by cranial irradiation: A review of the experimental evidence. Brain Behav. Immun. 45, 287–296. https://doi.org/10.1016/j.bbi.2015.01.007 (2015).
Greene-Schloesser, D. et al. Radiation-induced brain injury: A review. Front. Oncol. 2, 73. https://doi.org/10.3389/fonc.2012.00073 (2012).
Hendrickx, D. A. E., van Eden, C. G., Schuurman, K. G., Hamann, J. & Huitinga, I. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J. Neuroimmunol. 309, 12–22. https://doi.org/10.1016/j.jneuroim.2017.04.007 (2017).
Constanzo, J. et al. Brain irradiation leads to persistent neuroinflammation and long-term neurocognitive dysfunction in a region-specific manner. Prog. Neuropsychopharmacol. Biol. Psychiatry 102, 109954. https://doi.org/10.1016/j.pnpbp.2020.109954 (2020).
Altin, J. G. & Sloan, E. K. The role of CD45 and CD45-associated molecules in T cell activation. Immunol. Cell Biol. 75, 430–445. https://doi.org/10.1038/icb.1997.68 (1997).
Funding
This work was funded by National Natural Science Foundation of China (No. 82202958, 82272751), Natural Science Foundation of Shandong Province (ZR2021LSW002), Science Technology Program of Jinan (No. 202225019, 202225013), Higher Educational Institutions Youth Innovation Science and Technology Support Program of Shandong Province (2023KJL004) and China Postdoctoral Science Foundation (2023M734299).
Author information
Authors and Affiliations
Contributions
M.H. and M.Q.Z. contributed to the study conception and design. S.Y.Z. and X.C.D. wrote the main manuscript text. Y.Y.Z., Y.Y.L., X.W.W. and Y.J.G. contributed to the material preparation and data collection. Formal analysis and investigation were performed by J.G.Z., X.L., G.Z.G., Y.S. and L.Z.W. All authors commented on previous versions of the manuscript and all authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhou, S., Ding, X., Zhang, Y. et al. Evaluation of specific RBE in different cells of hippocampus under high-dose proton irradiation in rats. Sci Rep 14, 8193 (2024). https://doi.org/10.1038/s41598-024-58831-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-58831-z
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.